Tumor Immunology Flashcards
2 key cytokines that down-regulate T cell responses
TGF-beta and IL-10
Ligand that provides activatory signals to NK cells
MIC
MIC ligand provides activatory signals to NK cells through this
NKG2D
MIC ligand activates these cells
NK cells
Pembrolizumab, Nivolumab, and Cemiplimab are monoclonal antibodies against this
PD-1
Atezolizumab, Avelumab, and Durvalumab are monoclonal antibodies against this
PD-L1
PD-L1/PD-1 binding has this effect
Inhibits T cell killing of tumor cell
Blocking PD-L1/PD-1 binding has this effect
Allows T cell killing of tumor cell
Antigen for Gemtuzumab
CD33
CD33 is a marker for these
Immature myeloid cells
Gemtuzumab is used for this disease
Acute myelogenous leukemia
Ibritumomab is used for this disease
Non-Hodgkin’s lymphoma
Tositumomab is used for this disease
Non-Hodgkin’s Lymphoma
Monoclonal antibody against CD33 for treatment of acute myelogenous leukemia
Gemtuzumab
2 monoclonal antibodies that target CD20 in the treatment of Non-Hodgkin’s Lymphoma
Ibritumomab and Tositumomab
Antigen target of Ibritumomab
CD20
Antigen target of Tositumomab
CD20
Monoclonal antibody linked directly to the cytotoxic antibiotic dervided ozogamicin
Gemtuzumab
Gemtuzumab is linked directly to this
Cytotoxic antibiotic derived Ozogamicin
Monoclonal antibody linked through the chelator tiuxetan to indium-111 for imaging and yttrium-90 for treatment
Ibritumomab
Ibritumomab is linked through this to indium-111 for imaging and yttrium-90 for treatment
The chelator Tiuxetan
Ibritumomab is linked through the chelator tiuextan to this for imaging
Indium-111
Ibritumomab is linked through the chelator tiuextan to this for treatment
Yttrium-90
Monoclonal antibody that is linked to iodine-131
Tositumomab
Tositumomab is linked to this
Iodine-131
Vaccination using these proteins from dying tumor cells has demonstrated a potential for strong anti-tumor responses
Heat shock
T cell that recognizes antigen like a B cell (recognize protein)
Chimeric antigen receptor (CAR) T cells
How are CAR T cells different from regular TCRs?
Recognize proteins (antibody-like); recognize antigen directly
Normal TCRs recognize peptide:MHC
Fusion protein of antigen-binding region from heavy and light chains connected by a 10-25 amino acid linker
Single-chain variable fragment (scFv)